Compound ID | 2913
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Fatty acid synthesis inhibitor. Competitive inhibitor of NADH in InhA (an essential fatty acid synthesis enzyme) [InhA inhibitor] |
| Target Pathogen: | Active against Mycobacterium tuberculosis |
| Description: | Natural product from Streptomyces pyridomyceticus (also from Dactylosporangium fulvum); has activity against Mycobacteria tuberculosis in macrophages |
| Year first mentioned: | 2012 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/3037036 |
| Guide to Pharmacology: | pyridomycin |
| Citation: | https://www.embopress.org/doi/full/10.1002/emmm.201201689 |